BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 4103453)

  • 21. [Immunosuppression by means of antilymphocyte serums in humans].
    Revillard JP
    Nouv Rev Fr Hematol; 1972; 12(2):129-37. PubMed ID: 4264610
    [No Abstract]   [Full Text] [Related]  

  • 22. Intravenous antilymphocyte globulin in human cadaveric renal allotransplantation. Clinical and immunologic observations.
    Collste LG
    Acta Chir Scand; 1972; 138(8):765-74. PubMed ID: 4565721
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antilymphocyte serum: choice of antigen for its preparation and immunosuppression tests].
    Traeger J; Fries D; Perrin J; Saubier E; Revillard JP; Brochier J; Dubernard JM; Carraz M; Plan M; Archimbaud JP
    J Urol Nephrol (Paris); 1969 Sep; 75(9):584-9. PubMed ID: 4997175
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antilymphocyte serum: production, basic properties and clinical use (review of the literature)].
    Shabalin VN
    Vestn Khir Im I I Grek; 1972 Aug; 109(8):131-6. PubMed ID: 4126160
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunosuppression by antihuman lymphocyte globulin: correlation of human and animal assay systems with clinical results.
    Simmons RL; Moberg AW; Gewurz H; Soll R; Najarian JS
    Transplant Proc; 1971 Mar; 3(1):745-8. PubMed ID: 4999469
    [No Abstract]   [Full Text] [Related]  

  • 26. [Heterologous antilymphocyte serum and its use].
    Jasser S
    Pol Tyg Lek; 1970 May; 25(18):663-6. PubMed ID: 4393723
    [No Abstract]   [Full Text] [Related]  

  • 27. Antilymphocyte serum: a review with report of the current clinical situation in Australia.
    Sheil AG; Rogers JH
    Med J Aust; 1969 Jun; 1(26):1370-5. PubMed ID: 4183743
    [No Abstract]   [Full Text] [Related]  

  • 28. [Bone marrow transplantation and (or) immunosuppression with antithymocyte globulin in the treatment of aplastic anemia].
    Zwaan FE; Haak HL; van der Meer CW; Guiot HF; Hartgrink-Groeneveld CA; den Ottolander GJ; Willemze R; Eernisse JG; Brand A; van Rood JJ; Kunst MW; te Velde J; Noordwijk EM
    Ned Tijdschr Geneeskd; 1978 Mar; 122(10):326-32. PubMed ID: 24811
    [No Abstract]   [Full Text] [Related]  

  • 29. The intravenous administration of equine antilymphocytic globulin in renal transplant recipients and the detection of circulating antibodies to equine globulin.
    James K; Pullar DM; Morton JB; Dalton RG; Nolan B; Woodruff MF
    Clin Exp Immunol; 1971 Apr; 8(4):529-42. PubMed ID: 4995934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antilymphocyte serum and lymphatic system. I. The effect of regional administration on the survival of skin allografts.
    Málek P; Kolc J; Hasková V; Zástava V
    Transplantation; 1969 Oct; 8(4):333-7. PubMed ID: 4914422
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antilymphocyte serum. I].
    Bach JF
    Rev Eur Etud Clin Biol; 1970 Jan; 15(1):28-55. PubMed ID: 4393724
    [No Abstract]   [Full Text] [Related]  

  • 32. [Bases of antilymphocytic globulin and its therapeutic possibilities].
    Brendel W
    Arzneimittelforschung; 1970 Feb; 20(2):191-7. PubMed ID: 4191782
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of intravenous route for administration of antilymphocyte globulins in humans.
    Traeger J; Touraine JL; Fries D; Berthoux F
    Transplant Proc; 1971 Mar; 3(1):749-53. PubMed ID: 4937966
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunologic responses of graft recipients to antilymphocyte globulin: effect of prior treatment with aggregate-free gamma globulin.
    Weksler ME; Bull G; Schwartz GH; Stenzel KH; Rubin AL
    J Clin Invest; 1970 Aug; 49(8):1589-95. PubMed ID: 4194090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human antilymphocyte serum. 2. Further preparations and in vivo testing.
    Sutherland SK; Morris PJ; Broad AJ
    Med J Aust; 1970 Feb; 1(8):362-6. PubMed ID: 4392443
    [No Abstract]   [Full Text] [Related]  

  • 36. Whole antilymphocyte serum: a potent safe immunosuppressive agent for intravenous use in man.
    Levey RH; Parkman R
    Transplant Proc; 1977 Mar; 9(1):1019-22. PubMed ID: 405764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Our method for the production of antilymphocyte serum and the results of its experimental use].
    Metscharski St; Vasvasov N; Maimunkov K; Mozev D
    Z Exp Chir; 1972; 5(1):25-7. PubMed ID: 4156944
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies in immuno-suppression. Methods to evaluate anti-human lymphocyte sera.
    Balner H; Dersjant H; van Bekkum DW
    Transplant Proc; 1969 Mar; 1(1):629-37. PubMed ID: 5002666
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immune tolerance and antilymphocyte sera].
    Kaden J
    Z Arztl Fortbild (Jena); 1971 May; 65(9-10):522-8. PubMed ID: 5000438
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experimental and clinical administration of cytotoxic antilymphocyte serum and antilymphocyte globulin in homologous skin transplantation].
    Spasokukots'kii IuO; Gorodets'ka SF; Timoshenko IuG
    Fiziol Zh; 1971; 17(3):341-5. PubMed ID: 4118041
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.